Myositis

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Environmental Risk Factors for Myositis in Military Personnel

A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

Anti-inflammation Treatment for Idiopathic Inflammatory Myopathies

Environmental Risk Factors for the Anti-synthetase Syndrome

A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

Muscle Imaging Project Using ANatomopathology and Full Field Optical Coherence Tomography

Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies

Muscle Health Measurements Using Electrical Impedance Myography

Pregnancy and Medically Assisted Conception in Rare Diseases

Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases

Add-on Intravenous Immunoglobulins in Early Myositis

MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)

Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile Dermatomyositis

A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis

Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions

Multispectral Optoacustic Imaging in Patients With Myositis